Inventor · disambiguated record
Thomas Caya
Also filed as: CAYA THOMAS · CAYA THOMAS CHARLES
1 granted patent·2 pending applications·0 citations·filing 2021–2023
11Inventor score
Files withNOVARTIS AG3
Top patents by PatentIndex Score
3 records- 0159US2025145600A12-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesityNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0255US11453679B2Methyl 2-methyl-5-oxo-1,4,5,7-tetradhydrofuro[3,4-b]pyridine-3-carboxylate compounds as Cav1.2 activatorsNOVARTIS AG·Filed 2021·Granted Sep 27, 2022·0 cites·17 claims
- 0354US2024182456A12-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesityNOVARTIS AG·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Caya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →